home / stock / abbv / abbv articles

ABBV Articles, AbbVie Inc. - From 06/14/24

Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails | Benzinga

This week, an FDA advisory committee unanimously recommended approval of Eli Lilly's (NYSE: LLY) Alzheimer's disease drug, donanemab. Pfize...
Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry | Benzinga

In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive compa...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,100 Today | Benzinga

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.41% on an annualized basis producing an average annual return of 12.01%....

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside | Benzinga

Goldman Sachs has initiated coverage on Regenxbio Inc (NASDAQ:RGNX), citing the potential for the company’s gene therapy platform. The compan...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability | Benzinga

AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-pric...

AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a very solid pharmaceut...

Halozyme's ENHANZE Product Gets New Patent Grant in EU | Benzinga

Halozyme Therapeutics (NASDAQ: HALO) announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which ...
AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients | Benzinga

On Thursday, AbbVie Inc (NYSE:ABBV) released topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravtansi...

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU | Benzinga

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has a...

TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades' | Benzinga

On CNBC's “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors named The TJX Companies, Inc. (NYSE:TJX) a...
Previous 10 Next 10